Volume 63 • 2002 • Supplement 9

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Introduction: Cardiovascular and Metabolic Risks Associated With Schizophrenia and Antipsychotic Drug Treatment [Free]

J Clin Psychitary 2002;63(suppl 9):3-4

Risk of Cardiovascular Disease and Sudden Death in Schizophrenia

J Clin Psychiatry 2002;63(suppl 9):5-11

Clinical Management of Cardiovascular Risks During Treatment With Psychotropic Drugs

J Clin Psychiatry 2002;63(suppl 9):12-17

Mechanisms and Risks of Electrocardiographic QT Interval Prolongation When Using Antipsychotic Drugs

J Clin Psychiatry 2002;63(suppl 9):18-24

Assessing Cardiovascular Risks Versus Clinical Benefits of Atypical Antipsychotic Drug Treatment

J Clin Psychiatry 2002;63(suppl 9):25-29